CHEST Physician
-
CHEST 2025: An early look at the headlining topics
Get a sneak peek at the session topics each chest medicine niche will be covering at CHEST 2025 in Chicago.
-
Pride Month: Honoring identity and celebrating diversity
This Pride Month, let us lead with kindness and celebrate the vibrant spectrum of human identity that enriches our work as clinicians.
-
Shared decision-making in PAH
Shared decision-making is a collaborative process where clinicians and patients make informed health care decisions together, balancing medical evidence with patient values, which is especially important in complex conditions like PAH.
-
Opening the flood gates: Pleural complications of immune checkpoint inhibitors
The pulmonary and medical oncology community must start to consider pleural complications as a potential risk of immune checkpoint inhibitor therapy.
-
Pooled data suggest sotatercept as novel disease-modifying therapy for PAH
Aaron B. Waxman, MD, PhD, FCCP, said he believes the drug will become a first-line therapy option, but questions remain regarding when to initiate treatment.
-
Top-line results from FIBRONEER-ILD point to possible third agent for interstitial lung disease
If the data prove accurate, Barry Shea, MD, said nerandomilast could become the first new treatment for lung fibrosis in more than a decade.
-
Advanced practice respiratory therapist: The new advanced practice provider
The rise of the advanced practice respiratory therapist marks a pivotal advancement in respiratory care, addressing the growing need for specialized providers in health care.
-
Tezepelumab trial demonstrates solid results for treatment of CRSwNP
Joseph K. Han, MD, said the data showed the highest change in sinonasal outcome test scores from baseline compared with any other biologic studies for chronic rhinosinusitis with nasal polyps.
-
Turning the tide in right ventricular failure: The role of mechanical support
As mechanical circulatory support technologies advance, understanding the unique features of right-sided devices is essential for optimal patient selection.
-
Capillary refill time: Advancing perfusion-targeted resuscitation in septic shock
Capillary refill time is a quick, noninvasive tool to assess perfusion and microvascular health in shock. It offers faster feedback than lactate levels and may improve resuscitation outcomes.
